| ANOVA | one-way analysis of variance |
| APSCT | autologous peripheral stem-cell transplantation |
| BEAM | BCNU, etoposide, cytosine arabinoside, melphalan |
| BMT | bone marrow transplantation |
| CMR | complete morphologic remission |
| E2 | estradiol |
| EDTA | ethylenediaminetetraacetic acid |
| ELISA | enzyme linked immunosorbent assays |
| FA2BG2S2 | core fucosylated, sialylated bisecting biantennary glycan |
| GCF | gingival crevicular fluid |
| GVHD | graft-versus-host disease |
| HL | Hodkin lymphoma |
| Ig | immunoglobulin |
| IgA | immunoglobulin A |
| IgG | immunoglobulin G |
| sIgA | secretory immunoglobulin A |
| LPS | lipopolysaccharide |
| MM | multiple myeloma |
| NHL | non-Hodgkin lymphoma |
| OM | oral mucositis |
| PCA | principal component analysis |
| PCs | plasma cells |
| PR | partial remission |
| SC | secretory component |
| SF/NF | sialoform to neutral carbohydrate ratio |
| Z(IgA1) | IgA binding affibody protein derived from the Z-domain of Staphylococcal protein A |
| UWS | unstimulated whole saliva |
| VGPR | very good partial remission |
| WHO | World Health Organization |